Novel combined therapy extends life, diminishes pain in brain cancer patients

Novel combined therapy extends life, diminishes pain in brain cancer patients
Bob Carter, MD, PhD, (left) is UCSD Chief of Neurosurgery and performs this technique for patients at Moores Cancer Center. Santosh Kesari, MD, PhD, (right) who led this study, is chief of neuro-oncology at UC San Diego Moores Cancer Center. Credit: Courtesy of UCSD; Nick Abadilla Photography

Approximately five to ten percent of patients with primary or metastatic cancer suffer from devastating neurological complications such as headaches, seizures, confusion, difficulty swallowing and visual disturbances. These deficits are caused by a life-threatening form of brain invasion from cancer called neoplastic meningitis. Santosh Kesari, MD, PhD, at the University of California, San Diego School of Medicine and colleagues have utilized a novel combined technique to treat cancer patients by bathing the brain in chemotherapy and relieving pressure from spinal fluid build-up (hydrocephalus). The results of this multicenter study are described in Journal of Neurosurgery, now available online.

"What we have developed is a single intervention to treat both neoplastic meningitis and hydrocephalus," said Kesari, chief of neuro-oncology at UC San Diego Moores and associate professor of neurosciences at the UCSD School of Medicine. "Cancer should be fought by every method available, and this is an aggressive option that can dramatically improve function and survival for select patients."

When infiltrate the spaces within the brain, the cells prevent the flow and absorption of spinal fluid. This blockage causes increased pressure and fluid accumulation. By inserting an externally operated "off-on" valve along with an Ommaya reservoir – a small plastic device used to carry medicine to fluid in the brain and spinal cord – and shunt, doctors can both deliver chemotherapy directly to the brain's surfaces and drain excess fluids to the abdomen via a thin internal catheter.

"This dual-purpose technique allows for both diversion of excess spinal fluid and treatment of the underlying cancer," said Bob Carter, MD, PhD, UCSD chief of neurosurgery who performs the technique for patients at Moores Cancer Center. "When brain tumor care is coordinated by a multidisciplinary team such as ours, the results can significantly improve quality of life."

Kesari, who performed the original research on this technique at Harvard Medical School and Brigham and Women's Hospital, said that further studies need to be done to better understand and optimize this combined approach. Kesari and Carter are planning larger, prospective clinical studies to further optimize outcomes in metastatic brain .

add to favorites email to friend print save as pdf

Related Stories

Biomarker treatment for brain tumors studied

Jun 15, 2010

The Brain Tumor Unit at the Moores UCSD Cancer Center at the University of California, San Diego, is launching a clinical trial that will examine the use of biomarkers to advance the treatment of malignant gliomas, brain ...

Anti-cancer drug damages brain vessels

Feb 11, 2008

New research may help explain why an anti-cancer drug causes potentially fatal brain inflammation in certain patients. Scientists at Harvard Medical School mimicked the drug's activity in mice and found that it damaged the ...

Clinical trial evaluating brain cancer vaccine is underway

Oct 19, 2007

A clinical trial evaluating a brain cancer vaccine in patients with newly diagnosed brain cancer has begun at NYU Medical Center. The study will evaluate the addition of the vaccine following standard therapy with surgery ...

Drug combination shrinks breast cancer metastases in brain

Dec 16, 2007

A combination of a "targeted" therapy and chemotherapy shrank metastatic brain tumors by at least 50 percent in one-fifth of patients with aggressive HER2-positive breast cancer, according to data presented by Dana-Farber ...

Recommended for you

Better classification to improve treatments for breast cancer

3 hours ago

Breast cancer can be classified into ten different subtypes, and scientists have developed a tool to identify which is which. The research, published in the journal Genome Biology, could improve treatments and targeting of tre ...

Risk of diabetes up in hodgkin's lymphoma survivors

5 hours ago

(HealthDay)—Para-aortic radiation correlates with increased diabetes mellitus (DM) risk for Hodgkin's lymphoma (HL) survivors, according to a study published online Aug. 25 in the Journal of Clinical On ...

User comments